sever
acut
respiratori
syndrom
sar
becom
prioriti
healthcar
agenc
around
world
transmiss
associ
mortal
potenti
pandem
spread
decemb
case
identifi
worldwid
peopl
die
mortal
rate
world
health
organ
statist
http
novel
coronaviru
sar
coronaviru
sar
cov
identifi
caus
agent
sar
cov
markedli
differ
three
coronaviru
group
known
today
viru
genom
positivestrand
rna
kilobas
encod
rnadepend
rna
polymeras
four
main
viral
structur
protein
spike
envelop
e
membran
nucleocapsid
n
electron
microscopi
viral
particl
reveal
envelop
virion
diamet
rang
coronavirida
famili
protein
belong
famili
type
membran
glycoprotein
respons
bind
receptor
host
cell
membran
protein
also
contain
import
virusneutr
epitop
amino
acid
chang
protein
dramat
affect
viral
cellular
receptor
sar
cov
receptorbind
domain
rbd
protein
previou
studi
show
rbd
region
protein
play
critic
role
neutral
antibodi
induct
angiotensinconvert
enzym
bind
viru
deplet
rbdspecif
antibodi
sera
significantli
reduc
serumneutr
indic
domain
domin
neutral
antibodi
induct
protein
abund
structur
protein
span
membran
bilay
three
time
long
ctermin
cytoplasm
domain
insid
virion
short
ntermin
domain
n
protein
intern
phosphoprotein
molecular
weight
interact
viral
genom
rna
form
helic
small
e
protein
minor
structur
compon
contain
hydrophob
region
flank
hydrophil
previou
evid
indic
protein
play
key
role
coronaviru
assembl
virus
murin
hepat
viru
e
protein
requir
particl
format
interact
e
protein
result
viru
bud
protein
dispens
incorpor
present
report
two
recombin
baculovirus
construct
vacm
contain
e
gene
vac
contain
gene
two
virus
coinfect
cell
gener
viruslik
particl
vlp
western
blot
immunogold
label
indic
sar
cov
protein
assembl
vlp
sar
cov
vlp
induc
humor
cellular
immun
respons
sar
cov
character
mous
model
data
collect
show
sar
cov
vlp
induc
specif
antibodi
cellmedi
immun
respons
immun
mice
e
gene
sar
cov
amplifi
strain
genbank
access
revers
transcript
polymeras
chain
reaction
rtpcr
follow
primer
gene
gene
e
gene
product
gene
digest
bamhi
ecori
ligat
pfastbac
dual
control
polyhedron
promot
gener
pfb
pfbm
respect
e
gene
pcr
product
digest
smai
kpni
insert
pfbm
control
promot
gener
pfbme
construct
insert
acmnpv
bacmid
invitrogen
carlsbad
ca
transposit
recombin
bacmid
transfect
cell
use
lipofectin
produc
two
recombin
baculovirus
vac
vacm
viral
stock
prepar
manipul
accord
standard
cell
coinfect
vac
vacm
multipl
infect
moi
hr
postinfect
cell
medium
harvest
twice
phosphatebuff
salin
pb
lysat
pellet
g
hr
place
sucros
densiti
gradient
ww
ww
centrifug
g
hr
visibl
band
sucros
layer
collect
pellet
g
hr
pellet
resuspend
pb
presenc
sar
cov
vlp
purifi
prepar
analys
electron
microscopi
western
blot
electron
microscopi
use
examin
vlp
format
insect
cell
briefli
cell
infect
vac
vacm
moi
respect
coinfect
vac
vacm
moi
ninetysix
hour
postinfect
infect
cell
collect
fix
analys
electron
microscop
neg
stain
aliquot
vlp
sampl
place
carbonco
grid
stand
min
grid
stain
phosphotungst
acid
pta
min
pta
drain
grid
examin
directli
electron
microscop
immunogold
label
purifi
vlp
load
onto
collodionco
electron
microscop
grid
hr
remov
excess
sampl
solut
proteinspecif
antibodi
provid
linfa
wang
commonwealth
scientif
industri
research
organ
csiro
livestock
industri
australian
anim
health
laboratori
geelong
australia
ad
onto
grid
incub
hr
room
temperatur
follow
three
wash
pb
min
per
wash
room
temperatur
grid
incub
nm
goldconjug
antirabbit
immunoglobulin
g
hr
three
wash
pb
sampl
stain
pta
min
drain
examin
electron
microscop
eight
femal
balbc
mice
purchas
hubei
center
diseas
control
cdc
hubei
wuhan
china
randomli
divid
group
five
mice
per
group
given
pathogenfre
water
food
mainten
mice
immun
purifi
sar
cov
vlp
form
e
protein
day
vlp
immun
via
subcutan
inject
steril
pb
freund
adjuv
prime
stage
incomplet
freund
adjuv
boost
stage
mice
immun
pb
freund
adjuv
mixtur
neg
control
humor
immun
respons
sar
cov
immun
vlp
evalu
day
blood
sampl
collect
retroorbit
capillari
plexu
punctur
antibodi
titr
determin
use
elisa
briefli
plate
coat
inactiv
sar
cov
antigen
ng
per
well
pb
buffer
overnight
plate
block
pb
contain
bovin
serum
albumin
bsa
room
temperatur
hr
three
wash
pb
contain
dilut
sera
ad
plate
incub
hr
three
wash
alkalin
phosphatas
ap
conjug
antimous
immunoglobulin
g
ad
plate
hr
remov
unbound
conjug
wash
paranitrophenylphosph
pnpp
substrat
ad
plate
optic
densiti
od
read
nm
elisa
reader
result
given
arithmet
mean
standard
error
individu
test
neutral
antibodi
sar
cov
analys
use
sar
cov
proteinpseudotyp
murin
leukaemia
virus
mlv
cell
per
well
seed
cell
cultur
plate
plate
incub
overnight
confluent
monolay
form
serum
sampl
collect
day
heat
min
use
test
sera
dilut
twofold
incub
mlv
sar
pseudotyp
hr
sera
pbsimmun
mice
use
neg
control
incub
serumviru
mixtur
transfer
well
incub
plate
cell
cultur
plate
contain
cell
follow
hr
incub
serumviru
mixtur
replac
cell
cultur
medium
plate
incub
day
number
green
fluoresc
cell
count
fluoresc
microscop
neutral
effect
evalu
calcul
percentag
reduct
green
fluoresc
cell
number
serum
sampl
well
infect
pseudotyp
viru
comparison
well
mock
group
serum
sampl
infect
dose
pseudotyp
viru
ie
number
green
fluoresc
cell
control
well
number
green
fluoresc
cell
sampl
well
number
green
fluoresc
cell
control
well
ten
day
final
boost
immun
sar
cov
vlp
measur
splenocyt
spleen
accord
manufactur
protocol
mabtech
ab
stockholm
sweden
ninetysixwel
nitrocellulos
plate
coat
rat
antimous
pb
follow
overnight
incub
room
temperatur
plate
wash
three
time
pb
contain
block
pb
contain
fb
hr
three
wash
pb
contain
splenocyt
reaction
volum
contain
recombin
protein
specif
antigen
concanavalin
posit
control
medium
alon
neg
control
seed
well
plate
incub
overnight
wash
pb
biotinyl
antimous
monclon
antibodi
mab
dilut
ad
plate
incub
hr
room
temperatur
wash
peroxidas
ad
hr
room
temperatur
follow
five
wash
pb
individu
plate
develop
dark
spot
reaction
peroxidas
aec
reaction
stop
rins
well
deminer
water
plate
airdri
room
temperatur
read
elispot
reader
hitech
instrument
luton
uk
spotform
cell
sfc
per
splenocyt
calcul
medium
background
consist
sfc
per
splenocyt
studi
whether
vlp
form
insect
cell
cell
infect
recombin
baculovirus
vac
vacm
respect
analysi
cell
section
infect
vac
exhibit
particul
structur
cytoplasm
nucleu
howev
cell
infect
recombin
virus
vacm
larg
number
particul
structur
distribut
throughout
cytoplasm
shown
fig
infect
insect
cell
recombin
baculoviru
vacm
express
e
protein
vlp
observ
cytoplasm
hr
postinfect
diamet
approxim
nm
result
demonstr
e
protein
suffici
assembl
particl
alon
could
assembl
vlp
protein
contain
import
virusneutr
epitop
elicit
neutral
antibodi
host
speci
assembl
protein
vlp
usag
vaccin
insect
cell
coinfect
vacm
vac
moi
hr
postinfect
infect
cell
harvest
vlp
purifi
sucros
gradient
centrifug
vlp
observ
cytoplasm
infect
insect
cell
fig
investig
whether
protein
incorpor
within
vlp
purifi
vlp
assess
western
blot
use
sar
cov
sproteinspecif
antibodi
distinct
protein
band
approxim
molecular
weight
correspond
sar
cov
protein
detect
indic
protein
assembl
vlp
fig
addit
two
band
correspond
fig
e
fig
protein
detect
use
antibodi
e
protein
respect
result
show
sar
cov
vlp
contain
e
protein
examin
morpholog
vlp
locat
protein
particl
isol
vlp
immunogold
label
sproteinspecif
antibodi
observ
neg
stain
electron
microscopi
result
demonstr
presenc
protein
surfac
vlp
fig
immunogen
vlp
produc
insect
cell
evalu
immun
mice
mice
immun
via
subcutan
inject
four
time
day
time
sar
cov
vlp
serum
sampl
collect
immun
level
antibodi
respons
determin
elisa
use
inactiv
sar
cov
coat
antigen
data
demonstr
vlp
highli
immunogen
mice
shown
fig
day
prime
increas
antibodi
observ
sera
immun
group
antibodi
titr
immun
group
peak
day
first
boost
day
prime
antibodi
level
reduc
slightli
day
second
boost
day
prime
antibodi
level
began
increas
third
boost
day
prime
reach
plateau
day
prime
quantiti
antibodi
product
time
antibodi
level
mainten
show
typic
characterist
humor
immun
respons
result
show
sar
cov
vlp
induc
high
level
sarscovspecif
antibodi
mice
antibodi
titr
control
group
remain
baselin
throughout
studi
sar
cov
infect
initi
attach
protein
cellular
receptor
detect
neutral
activ
sera
immun
mice
cell
challeng
mlv
sar
pseudotyp
shown
fig
sera
vlpimmun
mice
exhibit
concentrationdepend
neutral
activ
neutral
reach
dilut
wherea
sera
control
mice
show
signific
neutral
activ
immun
respons
vaccin
mice
investig
measur
cytokin
product
type
immun
respons
determin
measur
marker
helper
type
respons
respons
shown
fig
immun
mice
sar
cov
vlp
result
approxim
increas
number
splenocyt
compar
mice
immun
pb
data
also
indic
product
significantli
less
splenocyt
isol
immun
mice
fig
suggest
cellular
respons
bia
report
sar
vaccin
belong
inactiv
viru
vaccin
subunit
make
inact
viru
vaccin
nativ
virus
need
grown
larg
scale
must
isol
inactiv
chemic
agent
process
expens
labori
riski
need
grow
handl
larg
quantiti
infecti
viru
therefor
inact
viru
strategi
limit
applic
safeti
consider
contrast
subunit
vaccin
safer
approach
import
advantag
subunit
vaccin
infecti
viru
entir
exclud
vaccin
product
consequ
risk
associ
product
revers
virul
genotyp
entir
elimin
howev
subunit
vaccin
base
recombin
protein
poorli
immunogen
incorrect
fold
target
protein
poor
present
immun
system
specif
class
subunit
vaccin
vlpbase
vaccin
current
investig
sever
human
virus
bluetongu
hepat
influenza
studi
demonstr
vlp
offer
promis
approach
recombin
vaccin
develop
robust
immunogen
abil
elicit
protect
neutral
antibodi
advantag
safeti
profil
baculoviru
express
vector
system
extens
use
produc
viruslik
particl
far
differ
vlp
human
anim
virus
includ
sar
cov
vlp
use
investig
viru
assembl
protein
interact
vaccin
deliveri
vector
current
studi
investig
assembl
sar
cov
vlp
insect
cell
use
recombin
baculovirus
construct
recombin
baculovirus
contain
sar
cov
e
gene
infect
insect
cell
examin
minimum
requir
vlp
format
result
show
e
protein
coexpress
insect
cell
gener
vlp
exhibit
spheriform
structur
resembl
sar
cov
virion
phenomenon
resembl
find
previou
studi
studi
use
vlp
investig
assembl
bud
sar
cov
particl
also
determin
possibl
applic
sar
cov
vaccin
therefor
intend
incorpor
protein
vlp
protein
receptor
bind
protein
play
crucial
role
viral
infect
main
target
neutral
antibodi
vaccin
design
upon
coinfect
insect
cell
vacm
vac
demonstr
sar
cov
vlp
form
visibl
infect
cell
view
electron
microscop
confirm
protein
incorpor
vlp
vlp
examin
electron
microscop
immunogold
label
electron
microscop
result
show
vlp
tag
along
goldconjug
immunoglobulin
g
indic
protein
assembl
vlp
success
incorpor
protein
onto
surfac
vlp
make
possibl
use
vlp
vaccin
sar
cov
investig
immunogen
vlp
mice
immun
purifi
vlp
serum
collect
interv
postimmun
test
elisa
examin
chang
neutral
antibodi
titr
observ
immunogen
mice
show
sar
cov
vlp
induc
high
level
neutral
antibodi
dynam
variat
specif
antibodi
titr
booster
immun
play
import
role
gener
high
level
specif
antibodi
neutral
activ
analys
protein
pseudotyp
mlv
show
vlpinduc
neutral
antibodi
neutral
infect
mlv
sar
pseudotyp
dilut
dilut
apart
humor
respons
sar
cov
vlp
also
induc
immun
respons
immun
associ
immun
respons
thought
essenti
control
intracellular
pathogen
therefor
chang
bia
immun
respons
may
attract
featur
sar
cov
vlp
vaccin
previou
studi
sar
cov
vlp
focus
assembl
virion
investig
report
construct
sar
cov
vlp
immunogen
potenti
use
antisar
vaccin
result
show
sar
cov
vlp
produc
insect
cell
induc
cellular
immun
respons
neutral
antibodi
sar
cov
protein
nonrepl
natur
lack
viral
genom
rna
make
vlp
safe
broad
repeat
applic
vlp
repeatedli
administ
vaccin
thu
repres
attract
vaccin
strategi
sar
infect
